Ingrid Hedenfalk
41 – 50 of 93
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes.
(
- Contribution to journal › Article
-
Mark
Transcriptional profiling of breast cancer metastases identifies liver metastasis-selective genes associated with adverse outcome in luminal A primary breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications.
(
- Contribution to journal › Article
-
Mark
Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.
(
- Contribution to journal › Article
- 2014
-
Mark
Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes.
(
- Contribution to journal › Article
-
Mark
Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancer.
(
- Contribution to journal › Article
-
Mark
Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.
(
- Contribution to journal › Article
-
Mark
Molecular profiling of male breast cancer - Lost in translation?
(
- Contribution to journal › Scientific review
-
Mark
71p * statin-induced anti-proliferative effects via cyclin d1 and p27 in a window-of-opportunity breast cancer trial.
(
- Contribution to journal › Published meeting abstract
-
Mark
32p * biomarkers and molecular subtypes in primary breast tumors and metastases: associations with liver metastases and outcome.
(
- Contribution to journal › Article